Literature DB >> 9160027

Pointwise univariate linear regression of perimetric sensitivity against follow-up time in glaucoma.

J M Wild1, N Hutchings, M K Hussey, J G Flanagan, G E Trope.   

Abstract

PURPOSE: The authors compared pointwise univariate linear regression (ULR) of sensitivity against follow-up as an indicator of visual field progression with that of the corresponding ULR of mean deviation (MD) and with the Glaucoma Change Probability (GCP) analysis. The authors determined the influence of the number and sequence of prior examinations on the slope of the pointwise function.
METHODS: Univariate linear regression was undertaken at each stimulus location on the arbitrarily assigned left eyes of 38 patients with glaucoma examined with the Humphrey Field Analyzer Programs 30-2 or 24-2 (stimulus size III, Humphrey Instruments Inc, San Leandro, CA). The mean age was 59.0 years (standard deviation [SD] = 12.9), the mean number of fields per patients was 12.0 (SD = 2.8), and the mean duration of follow-up was 6.0 years (SD = 1.6).
RESULTS: Four patients showed statistically significant MD slopes. Of the 34 patients exhibiting a nonsignificant MD slope, 15 exhibited clusters of at least two contiguous progressing locations. Less than half of these locations were designated as progressing by GCP. The GCP detected less than one third of the locations considered progressing by ULR for the last six fields in the series: this was attributed to the nonlinear nature of the decline in sensitivity.
CONCLUSIONS: The degree of agreement between the outcomes of ULR and GCP was dependent on the quality of the collected data, the magnitude of the baseline sensitivity, the extent and type of the subsequent visual field progression, and the position of the fields within the examination series. Good agreement was illustrated at those locations where the deterioration fell outside the limits of expected variability in stable glaucoma.

Entities:  

Mesh:

Year:  1997        PMID: 9160027     DOI: 10.1016/s0161-6420(97)30229-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  18 in total

1.  Frequency of testing for detecting visual field progression.

Authors:  S K Gardiner; D P Crabb
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

2.  The rate of visual field change in the ocular hypertension treatment study.

Authors:  Shaban Demirel; Carlos Gustavo V De Moraes; Stuart K Gardiner; Jeffrey M Liebmann; George A Cioffi; Robert Ritch; Mae O Gordon; Michael A Kass
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

3.  Improved prediction of rates of visual field loss in glaucoma using empirical Bayes estimates of slopes of change.

Authors:  Felipe A Medeiros; Linda M Zangwill; Robert N Weinreb
Journal:  J Glaucoma       Date:  2012-03       Impact factor: 2.503

4.  Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.

Authors:  John L Keltner; Chris A Johnson; Richard A Levine; Juanjuan Fan; Kimberly E Cello; Michael A Kass; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2005-09

5.  The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change.

Authors:  Felipe A Medeiros; Linda M Zangwill; Christopher Bowd; Kaweh Mansouri; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-05       Impact factor: 4.799

Review 6.  Detection of visual field progression in glaucoma with standard achromatic perimetry: a review and practical implications.

Authors:  Kouros Nouri-Mahdavi; Nariman Nassiri; Annette Giangiacomo; Joseph Caprioli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-26       Impact factor: 3.117

7.  Integrating event- and trend-based analyses to improve detection of glaucomatous visual field progression.

Authors:  Felipe A Medeiros; Robert N Weinreb; Grant Moore; Jeffrey M Liebmann; Christopher A Girkin; Linda M Zangwill
Journal:  Ophthalmology       Date:  2012-01-21       Impact factor: 12.079

Review 8.  Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.

Authors:  C Gustavo De Moraes; Jeffrey M Liebmann; Leonard A Levin
Journal:  Prog Retin Eye Res       Date:  2016-10-20       Impact factor: 21.198

9.  Refinement of pointwise linear regression criteria for determining glaucoma progression.

Authors:  Colleen M Kummet; K D Zamba; Carrie K Doyle; Chris A Johnson; Michael Wall
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-19       Impact factor: 4.799

10.  Incorporating risk factors to improve the assessment of rates of glaucomatous progression.

Authors:  Felipe A Medeiros; Linda M Zangwill; Kaweh Mansouri; Renato Lisboa; Ali Tafreshi; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.